Dyfyniad APA

Iede, K., Yamada, T., Kato, R., Ueda, M., Tsuda, Y., Nakashima, S., . . . Tominaga, S. (2019). Efficacy of S‐1 in second‐line chemotherapy after nab‐paclitaxel plus gemcitabine for patients with advanced pancreatic cancer. Cancer Rep (Hoboken).

Dyfyniad Arddull Chicago

Iede, Kiyotsugu, et al. "Efficacy of S‐1 in Second‐line Chemotherapy After Nab‐paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer." Cancer Rep (Hoboken) 2019.

Dyfyniad MLA

Iede, Kiyotsugu, et al. "Efficacy of S‐1 in Second‐line Chemotherapy After Nab‐paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer." Cancer Rep (Hoboken) 2019.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.